These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8881198)

  • 1. [Pleural effusion and severe edema of the lower limbs induced by bromocriptine].
    Messiaen T; Lefebvre C; Weynand B; Pieters T
    Rev Med Interne; 1996; 17(8):680-3. PubMed ID: 8881198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pleural effusion induced by bromocriptine].
    Diot E; Diot P; Le Rolland A; Jonville AP; Lasfargues G; Lemarie E; Lavandier M; Guilmot JL
    Rev Mal Respir; 1990; 7(2):175-7. PubMed ID: 2320790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pleuropulmonary disease as a side-effect of treatment with bromocriptine.
    Comet R; Domingo C; Such JJ; Ribera G; Sans J; Marín A
    Respir Med; 1998 Sep; 92(9):1172-4. PubMed ID: 9926176
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pleural effusion and constrictive pericarditis secondary to bromocriptine treatment].
    Saura J; Aguilar M; Alió J
    Neurologia; 1991 Nov; 6(9):331-3. PubMed ID: 1809340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pleuropulmonary disease during bromocriptine treatment of Parkinson's disease.
    McElvaney NG; Wilcox PG; Churg A; Fleetham JA
    Arch Intern Med; 1988 Oct; 148(10):2231-6. PubMed ID: 3178380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic constrictive pericarditis induced by long-term bromocriptine therapy: report of two cases.
    Champagne S; Coste E; Peyrière H; Nigond J; Mania E; Pons M; Hillaire-Buys D; Balmes P; Blayac JP; Davy JM
    Ann Pharmacother; 1999 Oct; 33(10):1050-4. PubMed ID: 10534217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pleural effusion during bromocriptine exposure in two patients with pre-existing asbestos pleural plaques: a relationship?
    Knoop C; Mairesse M; Lenclud C; Gevenois PA; De Vuyst P
    Eur Respir J; 1997 Dec; 10(12):2898-901. PubMed ID: 9493681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bromocriptine-induced pleuropneumopathy].
    Schmid PA; Suter T; Speich R; Eberli F; Greminger P
    Dtsch Med Wochenschr; 1994 Nov; 119(45):1543-6. PubMed ID: 7956789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diffuse interstitial lung disease without pleural involvement and high-dose bromocriptine].
    Marsaudon E; Castet D; Barrault MF; Allais C
    Rev Mal Respir; 1997 Nov; 14(5):405-7. PubMed ID: 9480488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pleural effusion and pulmonary hypertension in a patient with Parkinson disease treated with cabergoline].
    Haro-Estarriol M; Sabater-Talaverano G; Rodríguez-Jerez F; Obrador-Lagares A; Genís-Batlle D; Sendra-Salillas S
    Arch Bronconeumol; 2009 Feb; 45(2):100-2. PubMed ID: 19232272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Low dose pergolide induced systemic edema and pleural effusion in a patient with Parkinson's disease].
    Chihara N; Hayakawa M; Yoshimura M; Shiio Y; Nakase H
    Rinsho Shinkeigaku; 2008 Feb; 48(2):143-5. PubMed ID: 18326310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pleuropulmonary changes during long-term bromocriptine treatment for Parkinson's disease.
    Lancet; 1981 Jan; 1(8210):44-5. PubMed ID: 6109080
    [No Abstract]   [Full Text] [Related]  

  • 13. [Severe pleuropericarditis induced by long-term bromocriptin therapy, report of a case and review of the literature].
    Ciubotaru V; Poinsignon Y; Brunet-Bourgin F; Mestassi M; Rosenbaum D
    Rev Med Interne; 2004 Apr; 25(4):310-4. PubMed ID: 15050800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pleuropulmonary involvement during bromocriptine treatment.
    Kinnunen E; Viljanen A
    Chest; 1988 Nov; 94(5):1034-6. PubMed ID: 3180854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pleuropneumopathy caused by bromocriptine in a patient with Parkinson disease. Review of the literature apropos of a new case].
    Debove P; Simon F; Vaylet F; Renard JL; L'Her P
    Ann Med Interne (Paris); 1998 Apr; 149(3):167-71. PubMed ID: 11490541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Early pleuropulmonary toxicity associated with cabergoline, an antiparkinsonian drug].
    Villavicencio C; Ramírez-Sarmiento A; Gayete A; Grau S; Orozco-Levi M
    Arch Bronconeumol; 2007 Sep; 43(9):519-22. PubMed ID: 17919420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pleural disease during treatment with bromocriptine in patients previously exposed to asbestos.
    Hillerdal G; Lee J; Blomkvist A; Rask-Andersen A; Uddenfeldt M; Koyi H; Rasmussen E
    Eur Respir J; 1997 Dec; 10(12):2711-5. PubMed ID: 9493648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pergolide-induced dyspnea, bilateral pleural effusion and peripheral edema.
    Varsano S; Gershman M; Hamaoui E
    Respiration; 2000; 67(5):580-2. PubMed ID: 11070468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suggestive evidence for bromocriptine-induced pleurisy.
    Klaassen RJ; Troost RJ; Verhoeven GT; Krepel HP; van der Lely AJ
    Neth J Med; 1996 Jun; 48(6):232-6. PubMed ID: 8710045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Severe leg edema associated with the use of dopaminergic drugs in Parkinson's disease. Report of one case].
    Miranda C M; Hudson A L
    Rev Med Chil; 2017 Dec; 145(12):1624-1625. PubMed ID: 29652961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.